New treatments and perspectives in metastatic TNBC with PARP Inhibitors.
Benjamin VERRET
Oncologist, Villejuif, France
Oncologist, Villejuif, France
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
Fréderique PENAULT LORCA
Chairwoman of the Pathology department, University Hospital, Clermont Ferrand, France
9.00 I 9.15
Eric ZERBIB
Copyright © 2026 - BCU